The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer
Titel:
The effect of bevacizumab on serum soluble FAS/FASL and TRAIL and its receptors (DR4 and DR5) in metastatic colorectal cancer
Auteur:
Yildiz, Ramazan Benekli, Mustafa Buyukberber, Suleyman Kaya, Ali Osman Ozturk, Banu Yaman, Emel Berk, Veli Coskun, Ugur Yamac, Deniz Sancak, Banu Uner, Aytug